News

The voice of people with chronic obstructive pulmonary disease (COPD) becomes more pitched and sounds breathy or hoarse at the early stages of disease exacerbations, which are episodes when symptoms suddenly worsen, according to a pilot study where 28 patients were asked to record their voices every day for…

Adding GSK’s mepolizumab to standard inhaled treatment reduces the frequency of moderate to severe exacerbations in chronic obstructive pulmonary disease (COPD) patients with type 2 inflammation, which contributes to lung inflammation. That’s according to top-line data from a Phase 3 clinical trial called MATINEE (NCT04133909) announced by GSK…

DirectRx, a specialty pharmacy for people with chronic health disorders, is now part of the exclusive U.S. pharmacy network distributing Ohtuvayre (ensifentrine), a newly approved therapy for chronic obstructive pulmonary disease (COPD). The Verona Pharma therapy, with a list price of $2,950 for a monthly supply,…

A higher genetic risk for chronic obstructive pulmonary disease (COPD) is associated with reduced lung function starting in childhood, a study of more than 45,000 people across Europe shows. A person’s genetic makeup plays a key role in lung health early on, increasing the risk for COPD later in…

The U.S. Food and Drug Administration (FDA) has granted breakthrough designation to tezepelumab, an approved therapy for severe asthma, as an add-on maintenance treatment for moderate to very severe chronic obstructive pulmonary disease (COPD) marked by an eosinophilic profile. An eosinophilic profile refers to high blood levels of eosinophils,…

CVS Health has launched an environmental health impact initiative that aims to support patients with chronic conditions, including chronic obstructive pulmonary disease (COPD), for whom extreme weather events can worsen symptoms. At its onset, the initiative is focusing mainly on extreme heat events, providing excessive heat alerts and…

Exposure to certain air pollution gases — pollutants called volatile organic compounds (VOCs), especially benzene and toluene — significantly increases the risk of chronic obstructive pulmonary disease (COPD) among adults in the U.S., according to a new study. Indeed, one statistical model found COPD risk was three times higher…

People who get more vitamin E from their diet may be less likely to develop chronic obstructive pulmonary disease (COPD), an analysis suggests. Findings indicate that vitamin E supplementation may help in preventing COPD, but more research is needed to confirm this, researchers note. The study “…

Enrollment is now complete in a clinical trial testing RejuvenAir, CSA Medical’s minimally invasive device, in adults with chronic bronchitis — one of the most common forms of chronic obstructive pulmonary disease (COPD). The trial, called SPRAY-CB (NCT03893370), enrolled 210 patients at sites across the U.S. and…

Dupixent (dupilumab) has been approved by the European Commission as an add-on maintenance treatment for certain adults with uncontrolled chronic obstructive pulmonary disease (COPD). Specifically, the therapy from Sanofi and Regeneron Pharmaceuticals is now indicated for COPD patients in the European Union who have evidence of type…